We describe a procedure for enzyme immunoassay of theophylline (1,3-dimethyixanthine) in which all phases of the assay are totally automated in a Kinetic Analyzer (KA-1 50). This system permits assay of 75 10-tl samples per hour, with results available at 30-s intervals after initial sample preparation and preincubation. We compared results for 138 clinical samples by an ultraviolet method (x) and the present method (y). The slope of the comparison curve was 0.902, the y-intercept 0.402, and the correlation coefficient 0.984. The coefficient of variation for samples run in duplicate on the same day was 4.9%; it was 8.1 % for samples run on different days. Specificity, sensitivity, simplicity, speed, and small reagent requirement all make this an attractive alternative to chromatographic procedures.
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Theophylline (1,3-dimethylxanthine), a naturally occurring alkaloid closely related to caffeine, has long been used for treating bronchial asthma (I), and recently for treating apnea (2, 3) . Other indications for its use are as an adjunct to the treatment of acute left ventricular failure (4) and as an effective short-acting diuretic. The bronchodilating action of theophylline is not completely understood, but may be a result of phosphodiesterase inhibition, with a subsequent increase in cellular cyclic AMP (5), or of an intracellular shift in calcium ion (6), or both. Therapeutic and toxic concentrations of theophylline are not very different.
Mitenko and Ogilvie (7) estimate the therapeutic range necessary for improved pulmonary function to be 5 to 20 mg/liter of plasma. At higher concentrations, orally administered theophylline usually causes gastric discomfort, nausea, and vomiting. Many techniques are described in the literature for accurately monitoring serum theophylline (8) (9) (10) (11) (12) (13) (14) (15) (16) . We believe the assay described here has the following advantages, one or more of which the other procedures lack: high specificity, simplicity of performance, and automated speed. The EMIT assay (Syva Corp., Palo Alto, Calif. 94304) for theophylline is based on competitive protein binding, with glucose-6-phosphate dehydrogenase (EC 1.1.1.49) to label the drug and a theophylline antibody as the specific binding protein. The enzyme activity, monitored as a change in the absorbance of NADH at 340 nm, is directly related to the concentration of the drug in the sample (17) .
Here, we describe a totally mechanized adaptation of the EMIT theophylline assay to the KA-150 Kinetic Analyzer. 
Materials and Methods

Instrumentation
We used a Model KA-150 Kinetic Analyzer (Perkin-Elmer Corp., Norwalk, Conn. 06856) with auxiliary control panel, with the following settings: source, 340 nm; high-absorbance threshold, 1.5; low-absorbance threshold, 0.0; incubation, 24 5; direction up; enzyme mode; sensitivity high; and scale factor, 415. The instrument was first zeroed with diluent in both reagent-dispensing positions; then zero controls on the panel were adjusted.
A Hi Speed Dilutor (Micromedic Systems, Horsham, Pa. 19044) was also used.
Reagents
A preprepared EMIT reagent containing the theophylline antibody, glucose-6-phosphate, NAD, and 1-methylxanthine was reconstituted to 27 ml with de-ionized water and allowed to stabilize for 24 h at 4 #{176}C before use at room temperature in the R1 reagent-dispensing position.
EMIT reagent containing theophylline coupled to glucose-6-phosphate dehydrogenase was reconstituted to 27 ml with 2-amino-2-(hydroxymethyl)-1 ,3-propandiol hydrochloride (Tris.HC1) buffer (110 mmollliter, pH 7.9). This reagent, also allowed to stabilize at 4 #{176}C, was then used at room temperature in the R2 position.
EMIT buffer solution. Buffer was reconstituted to two ionic strengths. Buffer concentrate, 4 ml, was added to 26 ml of de-ionized water to make 0.110 mol/liter Tris.HC1 buffer, 27 ml of which was then used to reconstitute the EMIT reagent containing theophylline coupled to glucose-6-phosphate dehydrogenase. A 55 mmol/liter Tris.HC1 buffer was prepared as diluent in the diluent reservoir for use through the sample pick-up probe. This buffer was also used for predilution of sample with the Micromedic dilutor.
Procedure
EMIT calibrators and patients' sera were diluted 5.4-fold in duplicate on the Micromedic dilutor by adding 25 Ml to 100
Ml of 55 mmollliter Tris.HC1. Smaller sample volumes can be used, because the KA-150 picks up volumes as small as 10 Ml of the diluted sera. Following normal operating procedure, we loaded dilutions onto sample trays and assayed using reagents in their respective Another had a mean of 21.20, an SD of 1.059, and a CV of 4.997 (n = 10). "Day-to-day" precision was estimated by daily analyses during a seven-day period of a frozen pool that had a drug concentration of 10 mg/liter. The mean value was found to be 9.996 mg/liter with an SD of 0.820 and a CV of 8.198 (n = 26).
Comparative Results
Values obtained on the KA-150 were compared with those found by the Jatlow (9) modification of the Schack and Waxier (8) 
Specificity
A detailed cross-reactivity list (17) indicates excellent specificity for the antibody produced by the Syva Corp. According to the method procedure, a caffeine metabolite (1-methyixanthine) was added to the theophylline antibody to desensitize the assay to that compound. 3-Methylxanthine, a commonly occurring metabolite of theophylline, has a cross-reactivity of 3.0%.
Discussion
A recent abstractby Gushaw et al. (18) 
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